Belantamab Mafodotin Combination Therapy
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
Near Add Your Location
Sorting 42 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
- Accepting patients
- Show Principal Investigator
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Accepting patients
- Accepting patients
Memorial Sloan Kettering Bergen
Montvale, NJ
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
- Accepting patients
Memorial Sloan Kettering Commack
Commack, NY
- Accepting patients
- Show Principal Investigator
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
Memorial Sloan Kettering Westchester
West Harrison, NY
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.